Σύγκριση μεθόδων

	Memorial Symptom Assessment Scale (MSAS)	Λειτουργικός Δείκτης Διαβίωσης-Καρκίνος (FLIC)
Πεδίο	Ογκολογική Νοσηλευτική	Ογκολογική Νοσηλευτική
Οικογένεια	Process / pipeline	Process / pipeline
Έτος προέλευσης	1994	1984
Δημιουργός	Russell Portenoy	Henning Schipper
Τύπος	Patient self-report multisymptom prevalence and distress scale	Patient self-report functional living and quality-of-life scale
Θεμελιώδης πηγή	Portenoy, R. K., Thaler, H. T., Kornblith, A. B., et al. (1994). The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer, 30A(9), 1326–1336.	Schipper, H., Clinch, J., & Olweny, C. L. M. (1996). Quality of life studies: definitions and conceptual issues. In B. Spilker (Ed.), Quality of life and pharmacoeconomics in clinical trials (pp. 11–23). Lippincott-Raven.
Εναλλακτικές ονομασίες	MSAS, MSAS-SF	FLIC, Functional Living Index–Cancer
Συναφείς	4	4
Σύνοψη	The Memorial Symptom Assessment Scale is a comprehensive multisymptom instrument that captures both prevalence and distress of 32 cancer-related symptoms (full version) or 10 core symptoms (short form). Developed by Portenoy and colleagues at Memorial Sloan Kettering Cancer Center in 1994, the MSAS is designed for detailed symptom profiling in oncology research and clinical practice, enabling identification of symptom clusters and assessment of physical and psychological symptom burden separately.	The Functional Living Index-Cancer is a 22-item patient self-report instrument that measures health-related quality of life in cancer patients across physical, social, emotional, and overall QoL domains. Developed by Schipper and colleagues in the mid-1980s, the FLIC was among the first disease-specific QoL instruments for cancer and served as a foundational model for subsequent comprehensive measures like the EORTC QLQ-C30, bridging early generic QoL concepts with cancer-specific measurement.